Immunovia AB (publ) (STO:IMMNOV)
Sweden · Delayed Price · Currency is SEK 0.0801
-0.0085 (-9.59%)
Oct 19, 2026, 5:29 PM CET
Immunovia AB Market Cap
Immunovia AB has a market cap or net worth of 53.88 million as of October 19, 2026. It is the 44,175th most valuable company in the world and the 666th biggest in Sweden. Its market cap has decreased by 47.30% in one year.
Market Cap
53.88M
Enterprise Value
22.25M
Revenue
1.21M
Global Rank
Country Rank
#666 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since December 1, 2015, Immunovia AB's market cap has decreased from 424.45M to 53.88M, a decrease of -87.31%. That is a compound annual growth rate of -17.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 53.88M | -64.71% |
| Dec 30, 2025 | 152.70M | 64.79% |
| Dec 30, 2024 | 92.66M | 15.47% |
| Dec 29, 2023 | 80.25M | -86.52% |
| Dec 30, 2022 | 595.21M | -64.93% |
| Dec 30, 2021 | 1.70B | -37.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 151.87B |
| Getinge AB | 71.25B |
| Sectra AB | 61.04B |
| Medicover AB | 40.65B |
| Prostatype Genomics AB | 71.90M |
| Annexin Pharmaceuticals AB | 70.62M |
| AcouSort AB | 64.76M |
| Neem's Hill AB | 63.44M |